Updated: 10/13/2018


Review Topic
  • A 23-year-old man presents to the emeCXRrgency department with severe pleuritic chest pain. He tells the resident that he is worried he might have another collapsed lung.
  • One of two major presentations of Chronic Obstructive Pulmonary Disease (COPD)
    • including chronic bronchitis and emphysema
  • Characterized by decreased lung function in the setting of air outflow obstruction
  • Defined by alveolar wall destruction and dilation that presents in two forms
    • almost always  due to smoking (even if only secondhand)
    • panlobular is rare and caused by alpha1-antitrypsin deficiency
  • Patients identified as "pink puffers"
    • pink complexion due to hypoxic state, which is less severe than in "blue bloaters"
    • puffer describes compensatory hyperventilation necessary to normalize blood gas
  • Symptoms 
    • mild dyspnea
    • hyperventilation
    • mild cough
    • pinkish skin coloration
    • fatigue
  • Physical exam
    • late hypercarbia/hypoxia
    • barrel chest (increased AP chest diameter)
    • thin, wasted appearance
    • pursed-lip breathing
    • decreased heart and breath sounds
    • prolonged expiratory phase
    • end-expiratory wheezing
    • scattered rhonchi
    • digital clubbing (only in the presence of other comorbidities such as lung cancer, interstitial lung disease, or bronchiectasis)
  • Diagnosis is based highly on clinical observations
  • ABG
    • hypoxemia
      • decreased PO2
    • acute or chronic respiratory acidosis
      • increased PCO2
  • CXR
    • decreased lung markings with flattened diaphragm
    • hyperinflated lungs with bullae and/or blebs
    • thin-appearing heart and mediastinum
    • barrel-chest
  • PFTs
    • decreased FEV1 / FVC
    • normal or decreased FVC
    • normal or increased TLC (in emphysema and asthma, specifically)
    • decreased DLCO (in emphysema, specifically)
  • Blood cultures
    • order only if patient is febrile
    • Gram stain and sputum culture order in setting of fever or productive cough
  • Chronic bronchitis, asthma, bronchiectasis
  • Medical management 
    • O2, beta-agonists, anticholingerics, IV steroids, antibiotics
      • indicated for acute exacerbations
        • inhaled Beta-agonists
          • albuterol
        • inhaled anticholinergics
          • ipratropium, tiotropium
        • IV steroids 
        • broad-spectrum antibiotics 
          • use is controversial 
    • smoking cessation, ambulatory O2, bronchodilator, steroids, vaccines indicated for chronic disease
      • smoking cessation
      • ambulatory O2
        • resting PaO2 < 55mmHg or SaO2 <89%
      • bronchodilators
      • systemic or inhaled steroids
      • Pneumococcal and flu vaccines
    • respiratory support
      • CPAP or BiPAP if the patient's mental status is intact 
      • intubation if non-invasive measures fail or mental status is not intact
Prognosis, Prevention, and Complications
  • Prognosis
    • highly dependent of severity of disease, timing and adherence to treatment
    • disease cannot be reversed, only slowed
  • Prevention
    • alpha1-antitrypsin deficiency cannot be prevented, and should be managed accordingly
    • acute exacerbations and progression of disease secondary to smoking can be slowed with lifestyle modifications and strict adherence to treatment measures
  • Complications
    • if untreated or ignored, disease can progress rapidly leading to death

Please rate topic.

Average 5.0 of 2 Ratings

Thank you for rating! Please vote below and help us build the most advanced adaptive learning platform in medicine

The complexity of this topic is appropriate for?
How important is this topic for board examinations?
How important is this topic for clinical practice?
Questions (3)
Lab Values
Blood, Plasma, Serum Reference Range
ALT 8-20 U/L
Amylase, serum 25-125 U/L
AST 8-20 U/L
Bilirubin, serum (adult) Total // Direct 0.1-1.0 mg/dL // 0.0-0.3 mg/dL
Calcium, serum (Ca2+) 8.4-10.2 mg/dL
Cholesterol, serum Rec: < 200 mg/dL
Cortisol, serum 0800 h: 5-23 μg/dL //1600 h:
3-15 μg/dL
2000 h: ≤ 50% of 0800 h
Creatine kinase, serum Male: 25-90 U/L
Female: 10-70 U/L
Creatinine, serum 0.6-1.2 mg/dL
Electrolytes, serum  
Sodium (Na+) 136-145 mEq/L
Chloride (Cl-) 95-105 mEq/L
Potassium (K+) 3.5-5.0 mEq/L
Bicarbonate (HCO3-) 22-28 mEq/L
Magnesium (Mg2+) 1.5-2.0 mEq/L
Estriol, total, serum (in pregnancy)  
24-28 wks // 32-36 wks 30-170 ng/mL // 60-280 ng/mL
28-32 wk // 36-40 wks 40-220 ng/mL // 80-350 ng/mL
Ferritin, serum Male: 15-200 ng/mL
Female: 12-150 ng/mL
Follicle-stimulating hormone, serum/plasma Male: 4-25 mIU/mL
Female: premenopause: 4-30 mIU/mL
midcycle peak: 10-90 mIU/mL
postmenopause: 40-250
pH 7.35-7.45
PCO2 33-45 mmHg
PO2 75-105 mmHg
Glucose, serum Fasting: 70-110 mg/dL
2-h postprandial:<120 mg/dL
Growth hormone - arginine stimulation Fasting: <5 ng/mL
Provocative stimuli: > 7ng/mL
Immunoglobulins, serum  
IgA 76-390 mg/dL
IgE 0-380 IU/mL
IgG 650-1500 mg/dL
IgM 40-345 mg/dL
Iron 50-170 μg/dL
Lactate dehydrogenase, serum 45-90 U/L
Luteinizing hormone, serum/plasma Male: 6-23 mIU/mL
Female: follicular phase: 5-30 mIU/mL
midcycle: 75-150 mIU/mL
postmenopause 30-200 mIU/mL
Osmolality, serum 275-295 mOsmol/kd H2O
Parathyroid hormone, serume, N-terminal 230-630 pg/mL
Phosphatase (alkaline), serum (p-NPP at 30° C) 20-70 U/L
Phosphorus (inorganic), serum 3.0-4.5 mg/dL
Prolactin, serum (hPRL) < 20 ng/mL
Proteins, serum  
Total (recumbent) 6.0-7.8 g/dL
Albumin 3.5-5.5 g/dL
Globulin 2.3-3.5 g/dL
Thyroid-stimulating hormone, serum or plasma .5-5.0 μU/mL
Thyroidal iodine (123I) uptake 8%-30% of administered dose/24h
Thyroxine (T4), serum 5-12 μg/dL
Triglycerides, serum 35-160 mg/dL
Triiodothyronine (T3), serum (RIA) 115-190 ng/dL
Triiodothyronine (T3) resin uptake 25%-35%
Urea nitrogen, serum 7-18 mg/dL
Uric acid, serum 3.0-8.2 mg/dL
Hematologic Reference Range
Bleeding time 2-7 minutes
Erythrocyte count Male: 4.3-5.9 million/mm3
Female: 3.5-5.5 million mm3
Erythrocyte sedimentation rate (Westergren) Male: 0-15 mm/h
Female: 0-20 mm/h
Hematocrit Male: 41%-53%
Female: 36%-46%
Hemoglobin A1c ≤ 6 %
Hemoglobin, blood Male: 13.5-17.5 g/dL
Female: 12.0-16.0 g/dL
Hemoglobin, plasma 1-4 mg/dL
Leukocyte count and differential  
Leukocyte count 4,500-11,000/mm3
Segmented neutrophils 54%-62%
Bands 3%-5%
Eosinophils 1%-3%
Basophils 0%-0.75%
Lymphocytes 25%-33%
Monocytes 3%-7%
Mean corpuscular hemoglobin 25.4-34.6 pg/cell
Mean corpuscular hemoglobin concentration 31%-36% Hb/cell
Mean corpuscular volume 80-100 μm3
Partial thromboplastin time (activated) 25-40 seconds
Platelet count 150,000-400,000/mm3
Prothrombin time 11-15 seconds
Reticulocyte count 0.5%-1.5% of red cells
Thrombin time < 2 seconds deviation from control
Plasma Male: 25-43 mL/kg
Female: 28-45 mL/kg
Red cell Male: 20-36 mL/kg
Female: 19-31 mL/kg
Cerebrospinal Fluid Reference Range
Cell count 0-5/mm3
Chloride 118-132 mEq/L
Gamma globulin 3%-12% total proteins
Glucose 40-70 mg/dL
Pressure 70-180 mm H2O
Proteins, total < 40 mg/dL
Sweat Reference Range
Chloride 0-35 mmol/L
Calcium 100-300 mg/24 h
Chloride Varies with intake
Creatinine clearance Male: 97-137 mL/min
Female: 88-128 mL/min
Estriol, total (in pregnancy)  
30 wks 6-18 mg/24 h
35 wks 9-28 mg/24 h
40 wks 13-42 mg/24 h
17-Hydroxycorticosteroids Male: 3.0-10.0 mg/24 h
Female: 2.0-8.0 mg/24 h
17-Ketosteroids, total Male: 8-20 mg/24 h
Female: 6-15 mg/24 h
Osmolality 50-1400 mOsmol/kg H2O
Oxalate 8-40 μg/mL
Potassium Varies with diet
Proteins, total < 150 mg/24 h
Sodium Varies with diet
Uric acid Varies with diet
Body Mass Index (BMI) Adult: 19-25 kg/m2

Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Question locked
Sorry, this question is for
PEAK Premium Subscribers only
Upgrade to PEAK
Topic COMMENTS (4)
Private Note